Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | STAT6 | P42226 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL846811 | 0.81 | LMNA (0.30) | LMNACYP2C9 | |
| SCHEMBL847157 | 0.79 | NR1I2 (0.31) | — | |
| SCHEMBL12634644 | 0.79 | PKM (0.33) | — | |
| SCHEMBL847017 | 0.76 | DRD2 (0.33) | — | |
| SCHEMBL663921 | 0.76 | MEN1 (0.33) | NPC1RAB9ASMN1; SMN2NPSR1 | |
| SCHEMBL847067 | 0.76 | ALDH1A1 (0.36) | SMN1; SMN2 | |
| SCHEMBL12688265 | 0.74 | — | — | |
| SCHEMBL19500000 | 0.74 | FFAR3 (0.44) | FFAR3MAPK1LMNATP53CYP2C9 | |
| SCHEMBL17688059 | 0.74 | ATM (0.31) | — | |
| SCHEMBL353254 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112939927-A | SuFEx click reaction-based cyclic carbonate monomer, polymer and preparation method thereof | 苏州大学 | 2021-06-11 | — | — | CN | claimed |
| CN-109004280-B | Preparation method of all-solid-state polymer electrolyte and all-solid-state polymer battery | 珠海冠宇电池股份有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-109232929-B | Preparation method of gel polymer electrolyte and lithium ion battery | 珠海冠宇电池股份有限公司 | 2021-04-27 | — | — | CN | claimed |
| EP-2262845-A1 | MONOMERS AND POLYMERS WITH COVALENTLY-ATTACHED ACTIVE INGREDIENTS | University of Southern Mississippi (US) | 2010-12-22 | — | — | EP | claimed |
| WO-2009102795-A1 | MONOMERS AND POLYMERS WITH COVALENTLY-ATTACHED ACTIVE INGREDIENTS | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2009-08-20 | — | — | WO | claimed |
| US-20090208553-A1 | Monomers and Polymers with Covalently - Attached Active Ingredients | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2009-08-20 | — | — | US | claimed |
| US-12133895-B2 | Biodegradable functional polycarbonate nanoparticle carries for delivering molecular cargo | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2024-11-05 | — | — | US | disclosed |
| US-12128063-B2 | Biocompatible and biodegradable antiviral polymers | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2024-10-29 | — | — | US | disclosed |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-20230122378-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ANTIVIRAL POLYMERS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-04-20 | — | — | US | disclosed |
| US-20230122378-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ANTIVIRAL POLYMERS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-04-20 | — | — | US | disclosed |
| US-20220111115-A1 | A BONE CEMENT COMPOSITION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-04-14 | — | — | US | disclosed |
| EP-1904553-A1 | METHOD OF BIOMOLECULE IMMOBILIZATION ON POLYMERS USING CLICK-TYPE CHEMISTRY | Shoichet, Molly S. (CA) | 2008-04-02 | — | — | EP | disclosed |
| EP-1807113-A2 | SUSTAINED RELEASE OF ACTIVE MOLECULES FROM POLYMERS TOPICALLY APPLIED TO SKIN OR HAIR | ELC Management LLC (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2007003054-A1 | METHOD OF BIOMOLECULE IMMOBILIZATION ON POLYMERS USING CLICK-TYPE CHEMISTRY | SHOICHET MOLLY S (CA) | 2007-01-11 | — | — | WO | disclosed |
| WO-2006047714-A2 | SUSTAINED RELEASE OF ACTIVE MOLECULES FROM POLYMERS TOPICALLY APPLIED TO SKIN OR HAIR | ELC MANAGEMENT LLC (US) | 2006-05-04 | — | — | WO | disclosed |
| US-20060088489-A1 | Sustained release of active molecules from polymers topically applied to skin or hair | POLYTECHNIC UNIVERSITY | 2006-04-27 | — | — | US | disclosed |
| US-6972315-B2 | Enzyme-catalyzed polycondensations | SyntheZyme, LLC | 2005-12-06 | — | — | US | disclosed |
| US-20040019178-A1 | Enzyme-catalyzed polycondensations | SyntheZyme, LLC | 2004-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12133895-B2 | Biodegradable functional polycarbonate nanoparticle carries for delivering molecular cargo | ABCB11, ABCB1, PCBP1 | FFAR3 3787/4885MAPK1 2824/4885LMNA 1105/4885 |
| US-20230122378-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ANTIVIRAL POLYMERS | CD44, PUF60, SARS1 | FFAR3 2226/4885MAPK1 2292/4885LMNA 3066/4885 |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | FFAR3 2534/4885MAPK1 3441/4885LMNA 4337/4885 |
| US-12128063-B2 | Biocompatible and biodegradable antiviral polymers | CD44, PUF60, SARS1 | FFAR3 2226/4885MAPK1 2292/4885LMNA 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.